Found: 11
Select item for more details and to access through your institution.
eNOS S-nitrosylates β-actin on Cys374 and regulates PKC-θ at the immune synapse by impairing actin binding to profilin-1.
- Published in:
- PLoS Biology, 2017, v. 15, n. 4, p. 1, doi. 10.1371/journal.pbio.2000653
- By:
- Publication type:
- Article
ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1502, doi. 10.3390/ijms21041502
- By:
- Publication type:
- Article
Overcoming tumor resistance mechanisms in CAR-NK cell therapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.953849
- By:
- Publication type:
- Article
Myc-Related Mitochondrial Activity as a Novel Target for Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1662, doi. 10.3390/cancers13071662
- By:
- Publication type:
- Article
The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 217, doi. 10.3390/cancers13020217
- By:
- Publication type:
- Article
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1188818
- By:
- Publication type:
- Article
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1188818
- By:
- Publication type:
- Article
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1188818
- By:
- Publication type:
- Article
P-007: Exploring a safety switch in NKG2D and BCMA CAR NK-92MI immunotherapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S42, doi. 10.1016/S2152-2650(21)02141-8
- By:
- Publication type:
- Article
Exploring NKG2D and BCMA-CAR NK-92 for Adoptive Cellular Therapy to Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e24, doi. 10.1016/j.clml.2019.09.036
- By:
- Publication type:
- Article
NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00537-w
- By:
- Publication type:
- Article